Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M35,759Revenue $M6,417Net Margin (%)19.9Altman Z-Score4.4
Enterprise Value $M37,179EPS $6.6Operating Margin %22.7Piotroski F-Score4
P/E(ttm)27.3Beneish M-Score-2.5Pre-tax Margin (%)21.4Higher ROA y-yN
Price/Book3.410-y EBITDA Growth Rate %--Quick Ratio0.4Cash flow > EarningsY
Price/Sales5.75-y EBITDA Growth Rate %21.7Current Ratio0.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-42.4ROA % (ttm)7.1Higher Current Ratio y-yN
Dividend Yield %0.4PEG1.3ROE % (ttm)13.8Less Shares Outstanding y-yN
Payout Ratio %10.0Shares Outstanding M200ROIC % (ttm)11.2Gross Margin Increase y-yY

Gurus Latest Trades with SHPG

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SHPGKen Fisher 2016-03-31 Add$150.4 - $205
($168.09)
$ 177.466%Add 16.80%39,657
SHPGLeon Cooperman 2015-12-31 Sold Out -0.19%$188.55 - $231.08
($207.82)
$ 177.46-15%Sold Out0
SHPGJohn Paulson 2015-12-31 Add0.05%$188.55 - $231.08
($207.82)
$ 177.46-15%Add 0.58%6,844,800
SHPGKen Fisher 2015-12-31 Add$188.55 - $231.08
($207.88)
$ 177.46-15%Add 9.30%33,954
SHPGLeon Cooperman 2015-09-30 Reduce-1.74%$197.88 - $268.08
($237.86)
$ 177.46-25%Reduce -90.86%45,367
SHPGJohn Paulson 2015-09-30 Reduce-0.33%$197.88 - $268.08
($237.86)
$ 177.46-25%Reduce -4.09%6,805,200
SHPGKen Fisher 2015-09-30 Add$197.88 - $268.08
($237.86)
$ 177.46-25%Add 54.08%31,064
SHPGJohn Paulson 2015-06-30 Reduce-1.55%$226.9 - $260.15
($247.87)
$ 177.46-28%Reduce -14.81%7,095,100
SHPGFirst Eagle Investment 2015-06-30 Reduce-0.17%$226.9 - $260.15
($247.87)
$ 177.46-28%Reduce -98.36%4,830
SHPGLeon Cooperman 2015-06-30 Reduce-0.02%$226.9 - $260.15
($247.87)
$ 177.46-28%Reduce -0.80%496,192
SHPGKen Fisher 2015-06-30 Add$226.9 - $260.15
($247.87)
$ 177.46-28%Add 36.31%20,161
SHPGFirst Eagle Investment 2015-03-31 Add0.12%$205.66 - $253.64
($229.81)
$ 177.46-23%Add 254.93%294,539
SHPGLeon Cooperman 2015-03-31 Add0.1%$205.66 - $253.64
($229.81)
$ 177.46-23%Add 5.70%500,192
SHPGMario Gabelli 2015-03-31 Sold Out -0.018%$205.66 - $253.64
($229.81)
$ 177.46-23%Sold Out0
SHPGKen Fisher 2015-03-31 Add$205.66 - $253.64
($229.81)
$ 177.46-23%Add 1.35%14,791
SHPGLeon Cooperman 2014-12-31 Buy 1.7%$170.49 - $262.71
($211.39)
$ 177.46-16%New holding473,237
SHPGJohn Paulson 2014-12-31 Reduce-0.77%$170.49 - $262.71
($211.41)
$ 177.46-16%Reduce -7.93%8,328,304
SHPGDavid Tepper 2014-12-31 Sold Out -0.71%$170.49 - $262.71
($211.58)
$ 177.46-16%Sold Out0
SHPGFirst Eagle Investment 2014-12-31 Add0.04%$170.49 - $262.71
($211.58)
$ 177.46-16%Add 453.24%82,986
SHPGMario Gabelli 2014-12-31 Reduce-0.03%$170.49 - $262.71
($211.58)
$ 177.46-16%Reduce -57.13%16,225
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SHPG is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SHPG: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about SHPG:

News about SHPG:

Articles On GuruFocus.com
Tweedy Browne Fund 4th Quarter Commentary Jan 27 2016 
John Paulson Sells Stake in Broadcom, Cuts Cablevision Holding Nov 18 2015 
Undervalued Baxalta Shares Target of Acquisition by Shire Plc Aug 05 2015 
Manning & Napier's Top 5 New Stock Buys of Q2 Jul 09 2015 
Manning & Napier Invests in Stake in Baidu Jul 08 2015 
Invesco European Growth Fund Parts With Two Stakes Jul 01 2015 
Andreas Halvorsen Increases Stake in Esperion Therapeutics Jun 29 2015 
Smart Guru John Paulson Bullish on Actavis Jun 18 2015 
8 Top Healthcare Stocks to Watch May 13 2015 
John Paulson's Stocks Trading at Low P/E May 04 2015 

More From Other Websites
​Here are the local biotechs devoting the biggest chunk of their budget to R&D May 04 2016
Will Midatech Pharma plc be the next Shire plc? May 04 2016
SHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 03 2016
Shire Plc :SHPG-US: Earnings Analysis: Q1, 2016 By the Numbers May 03 2016
Director/PDMR Shareholding May 03 2016
Total Voting Rights May 03 2016
Shire (SHPG) Tops Q1 Earnings, Baxalta Buyout Set for June May 02 2016
SHIRE PLC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,... Apr 29 2016
Why These Five Stocks Are on the Move Today? Apr 29 2016
FTSE 100 slides, but hangs on to monthly gain Apr 29 2016
[$$] Shire Posts First-Quarter Profit, Revenue Growth Apr 29 2016
Shire Quarterly Profit Tops Estimates as Drug Sales Soar Apr 29 2016
Shire delivers strong Q1 2016 results ... Apr 29 2016
Shire Delivers Strong Q1 2016 Results With Double-digit Growth in Revenue and Non GAAP Earnings Per... Apr 29 2016
First Quarter 2016 Results Apr 28 2016
Baxalta (BXLT) Beats on Q1 Earnings, Set to Merge with Shire Apr 28 2016
Royal London, Hermes take aim at UK plc pay plans Apr 28 2016
[$$] Shire Shareholders Rebel Over CEO Pay Apr 28 2016
The Zacks Analyst Blog Highlights: Newell Brands, Hormel Foods, Shire and PAREXEL International Apr 28 2016
The Zacks Analyst Blog Highlights: Johnson & Johnson, Biogen, Novartis, Baxalta Incorporated and... Apr 28 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)